FOXJ1, also known as HNF-4, is thought to inhibit tumor growth by resisting NF-κB activity, and FOXJ1 is ubiquitous in hypermethylated tumors and it is suggested that FOXJ1 silencing is an important potential factor in breast tumor formation 35. Here, HNF4A is linked to neoplasm.